CARMEL,
Ind., Feb. 6, 2024 /PRNewswire/ -- Syra Health
Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare
technology company with a mission to improve healthcare by
providing innovative services and technology solutions, announced
today it has been awarded a one-year contract with the District of Columbia's Department of
Behavioral Health worth approximately $250,000.
The D.C. Department of Behavioral Health provides prevention,
intervention, and treatment services and support for children,
youth, and adults with mental and/or substance use disorders
including emergency psychiatric care and community-based outpatient
and residential services.
Under the contract, Syra Health will conduct an epidemiological
study aimed at identifying the prevalence and types of behavioral
health conditions that exist among youth in the district. Once it
has completed the study, Syra Health will also provide a detailed
report of its outcomes.
"Our mixed methods researchers, allow us to deploy analytical
and statistical tools necessary for producing this study," said
Srikant Devaraj, PhD, Vice President
of Health Analytics, Syra Health. "We believe epidemiological
studies like this one will benefit other states beyond Washington D.C., as the nation continues to
wrestle with behavioral health conditions."
"We are continuing to win contracts at a steady pace," said Dr.
Deepika Vuppalanchi, CEO of Syra
Health. "Our pipeline of contracts remains robust, and we expect to
announce more wins as they are executed."
ABOUT SYRA HEALTH
Syra Health is a healthcare technology company addressing some
of healthcare's most significant challenges in areas such as
behavioral and mental health, digital health, and population
health, by providing innovative services and technology solutions.
Syra Health's products and services are centered on prevention,
improved access, and affordable care. Syra Health supplies its
solutions to payers, providers, life sciences organizations,
academic institutions, and the government. For more information,
please visit www.syrahealth.com.
Forward-Looking Statements
Statements in this press release about future expectations,
plans, and prospects, as well as any other statements regarding
matters that are not historical facts, may constitute
"forward-looking statements." These statements include but are not
limited to, statements relating to the expected use of proceeds,
the Company's operations and business strategy, and the Company's
expected financial results. The words "anticipate," "believe,"
"continue," "could," "estimate," "expect," "intend," "may," "plan,"
"potential," "predict," "project," "should," "target," "will,"
"would" and similar expressions are intended to identify
forward-looking statements, although not all forward-looking
statements contain these identifying words. The forward-looking
statements contained in this press release are based on
management's current expectations and are subject to substantial
risks, uncertainty, and changes in circumstances. Investors should
read the risk factors outlined in our registration statement on
Form S-1 and other periodic reports filed with the Securities and
Exchange Commission. Any forward-looking statements contained in
this press release speak only as of the date hereof, and, except as
required by federal securities laws, the Company specifically
disclaims any obligation to update any forward-looking statements,
whether as a result of new information, future events, or
otherwise.
For Media Inquiries:
Syra Health Corp.
Communications and Marketing Director
Christine Drury
317-385-9227
christined@syrahealth.com
For Investor Inquiries:
Ben
Shamsian
Vice President
Lytham Partners, LLC
646-829-9701
shamsian@lythampartners.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/syra-health-announces-a-one-year-contract-worth-approximately-250-000-with-washington-dc-department-of-behavioral-health-302054717.html
SOURCE Syra Health